• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

    1.130 +0.040 (+3.67%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 198,179
    Open 1.100
    Bid (Size) 1.050 (900)
    Ask (Size) 1.170 (900)
    Prev. Close 1.090
    Today's Range 1.080 - 1.225
    52wk Range 0.8750 - 12.88
    Shares Outstanding 6,297,303
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Revelation Biosciences Announces Adoption of Stockholder Rights Plan
    From Revelation Biosciences, Inc.
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences Expands Acute Kidney Injury Advisory Board
    Via ACCESS Newswire

    Performance

    YTD
    -65.3%
    -65.3%
    1 Month
    +17.6%
    +17.6%
    3 Month
    -5.8%
    -5.8%
    6 Month
    -68.6%
    -68.6%
    1 Year
    -90.5%
    -90.5%

    More News

    Read More
    News headline image
    Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
    Via ACCESS Newswire
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
    Via ACCESS Newswire
    News headline image
    REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
    Via ACCESS Newswire
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    News headline image
    REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year ↗
    Via Stocktwits
    News headline image
    American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements
    Via AB Newswire
    What's going on in today's session ↗
    Via Chartmill
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    Which stocks are moving on Friday? ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Friday. ↗
    Via Chartmill
    Thursday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
    Via ACCESS Newswire
    News headline image
    Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Revelation Biosciences, Inc. - Common Stock publicly traded?
    Yes, Revelation Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Revelation Biosciences, Inc. - Common Stock trade on?
    Revelation Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Revelation Biosciences, Inc. - Common Stock?
    The ticker symbol for Revelation Biosciences, Inc. - Common Stock is REVB on the Nasdaq Stock Market
    What is the current price of Revelation Biosciences, Inc. - Common Stock?
    The current price of Revelation Biosciences, Inc. - Common Stock is 1.130
    When was Revelation Biosciences, Inc. - Common Stock last traded?
    The last trade of Revelation Biosciences, Inc. - Common Stock was at 07/16/26 04:00 PM ET
    What is the market capitalization of Revelation Biosciences, Inc. - Common Stock?
    The market capitalization of Revelation Biosciences, Inc. - Common Stock is 7.12M
    How many shares of Revelation Biosciences, Inc. - Common Stock are outstanding?
    Revelation Biosciences, Inc. - Common Stock has 7M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.